Related Experiment Videos
Treatment of growth hormone insufficiency
1Endocrine Unit, Middlesex Hospital, London, UK.
Insights
Optimizing growth hormone therapy for children involves understanding secretory burst amplitude and dose. Proper dosing (at least 20 U/m2/week) and administration frequency are crucial for effective growth hormone treatment.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Physiology
- Childhood Growth Disorders
Background:
- Childhood growth is primarily regulated by growth hormone (GH) secretion.
- GH secretion is characterized by pulsatile bursts, with amplitude being more critical than frequency for modulating growth.
- Understanding GH dynamics is essential for effective therapeutic interventions.
Purpose of the Study:
- To define optimal growth hormone (GH) dosing and administration strategies for children with GH insufficiency.
- To highlight the importance of considering specific conditions like Turner's syndrome in treatment response.
- To elucidate the role of GH secretory burst amplitude versus frequency in promoting growth.
Main Methods:
- Analysis of growth hormone secretory patterns, focusing on burst amplitude and frequency.
- Review of therapeutic dosing regimens for growth hormone insufficiency.
- Comparative assessment of growth responses in different pediatric populations.
Main Results:
- Growth hormone secretory burst amplitude is the predominant factor modulating childhood growth.
- Optimal therapy for severe GH insufficiency requires a minimum dose of 20 U/m2 body surface area/week.
- Growth response varies significantly between conditions such as classical GH insufficiency and Turner's syndrome.
Conclusions:
- Therapeutic optimization of growth hormone requires careful consideration of both dose and administration frequency.
- Individual patient conditions, like Turner's syndrome, necessitate tailored growth hormone treatment approaches.
- Accurate assessment of growth hormone secretory dynamics aids in personalized pediatric growth management.
Abstract:
Growth during childhood is growth hormone dependent and is modulated predominantly by the amplitude of the growth hormone secretory bursts while the frequency of these episodes remains relatively constant at 180-200 min. Optimisation of therapy for children with growth hormone insufficiency requires a clear definition of the dose of the growth hormone required to promote growth which in severely insufficient children is at least 20 U/m2 body surface area/week. The frequency of administration of growth hormone is equally important in determining response, and interpretation of any result of therapy condition that is being treated also needs to be carefully considered. Children with Turner's syndrome will not have the same growth response as children who have classical growth hormone insufficiency.